Sep 24, 2026, cs.AIJ/K move · Enter open · S save
Muhammad Muhtasim Shahriar, Abdullah Mohammad Sayem, Tze Hui Liew, M. F. Mridha+1
Department of Computer Science, International Islamic University Chittagong, Chittagong, Bangladesh · Centre for Intelligent Cloud Computing, Centre of Excellence for Advanced Cloud, Faculty of Information Science and Technology, Multimedia University, Melaka, Malaysia · Multimedia University, Jalan Ayer Keroh Lama, 75450 Bukit Beruang, Melaka, Malaysia+1
Consumer-facing skincare AI must coordinate visual evidence, product information, tool use, and user-facing actions within explicit evidence and safety boundaries. This study evaluates SkinAgent AI, a non-diagnostic multimodal framework that combines visual concern routing with grounded and auditable LLM-based orchestration. The architecture includes routing for Acne, Pores, and Wrinkles; photograph-based skin-type estimation; count-informed ordinal acne-severity support; typed tools; database-grounded recommendation and action functions; deterministic safety, privacy, and evidence checks; approval before state-changing actions; and structured trace and replay mechanisms. Visual-model performance and system-level agent behavior were evaluated separately. Across three seeds, the skin-condition routing model achieved 99.84% +/- 0.07% accuracy. Skin-type estimation achieved 88.85% accuracy, while count-informed acne-severity support achieved 84.59% accuracy with a quadratic weighted kappa of 0.9076. On a locked but non-independent 240-case system benchmark, intent accuracy was 80.00%, exact tool-set match was 62.92%, and strict task completion was 47.08%. No violations or successful cross-user leakage events were observed in the finite safety and privacy test suites. Tool-selection errors, incomplete grounding of product attributes, and unreliable failure fallback nevertheless remained. These findings support the feasibility of bounded, database-grounded, and traceable agent orchestration for non-diagnostic skincare assistance. They do not establish clinical readiness, external generalization, formal privacy guarantees, or universal safety. Independent validation, expert assessment, robustness and fairness testing, and prospective evaluation in real-world settings remain necessary.